CISPLATIN INJECTION SOLUTION Kanada - Inggeris - Health Canada

cisplatin injection solution

strides pharma canada inc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

CISPLATIN INJECTION SOLUTION Kanada - Inggeris - Health Canada

cisplatin injection solution

teva canada limited - cisplatin - solution - 1.0mg - cisplatin 1.0mg - antineoplastic agents

CISPLATIN INJECTION SOLUTION Kanada - Inggeris - Health Canada

cisplatin injection solution

fresenius kabi canada ltd - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

CISPLATIN INJECTION BP SOLUTION Kanada - Inggeris - Health Canada

cisplatin injection bp solution

hikma canada limited - cisplatin - solution - 1mg - cisplatin 1mg

CISPLATIN INJECTION, MYLAN STD. SOLUTION Kanada - Inggeris - Health Canada

cisplatin injection, mylan std. solution

mylan pharmaceuticals ulc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

CISPLATIN INJECTION BP SOLUTION Kanada - Inggeris - Health Canada

cisplatin injection bp solution

pfizer canada ulc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

DBL CISPLATIN 100mg/100mL Injection Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

dbl cisplatin 100mg/100ml injection

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium chloride - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

DBL CISPLATIN 50mg/50mL Injection Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

dbl cisplatin 50mg/50ml injection

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; mannitol; water for injections - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

CISPLATIN injection, solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cisplatin injection, solution

fresenius kabi usa, llc - cisplatin (unii: q20q21q62j) (cisplatin - unii:q20q21q62j) -

CISPLATIN injection, solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cisplatin injection, solution

apotex corp. - cisplatin (unii: q20q21q62j) (cisplatin - unii:q20q21q62j) -